Forest Laboratories, LLC et al v. Lupin Limited et al > Summary
Court Case Number 1:14-cv-01058
Filing Date Aug 15, 2014
Court Delaware District Court
Status Unknown
Plaintiff Attorneys
6Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Defendant Attorneys
11Lupin Pharmaceuticals
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Lupin Pharmaceuticals
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Amerigen Pharmaceuticals
Attorney Name: Kelly E. Farnan
Richards, Layton & Finger, P.A.
Amerigen Pharmaceuticals
Attorney Name: Kelly E. Farnan
Richards, Layton & Finger, P.A.
Lupin Pharmaceuticals
Attorney Name: Clifford Katz
Kelley Drye & Warren
Lupin Pharmaceuticals
Attorney Name: Richard D. Kirk
Bayard, P.A.
Lupin Pharmaceuticals
Attorney Name: Richard D. Kirk
Bayard, P.A.
Anchen Pharmaceuticals, Inc.
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
PAR Technology
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
Anchen Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
PAR Technology
Attorney Name: John W. Shaw
Shaw Keller LLP
Counter Defendant
6Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Supernus Pharmaceuticals
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Allergan
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Counter Claimant
8Amerigen Pharmaceuticals
Attorney Name: Kelly E. Farnan
Richards, Layton & Finger, P.A.
Lupin Pharmaceuticals
Attorney Name: Richard D. Kirk
Bayard, P.A.
Lupin Pharmaceuticals
Attorney Name: Richard D. Kirk
Bayard, P.A.
Anchen Pharmaceuticals, Inc.
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
PAR Technology
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
Anchen Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
PAR Technology
Attorney Name: John W. Shaw
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08598233 | Method for administering an NMDA receptor antagonist to a subject | Dec 3, 2013 |
08362085 | Method for administering an NMDA receptor antagonist to a subject | Jan 29, 2013 |
08329752 | Composition for administering an NMDA receptor antagonist to a subject | Dec 11, 2012 |
08283379 | Methods and compositions for the treatment of CNS-related conditions | Oct 9, 2012 |
08173708 | Method and composition for administering an NMDA receptor antagonist to a subject | May 8, 2012 |
08168209 | Method and composition for administering an NMDA receptor antagonist to a subject | May 1, 2012 |
08039009 | Modified release formulations of memantine oral dosage forms | Oct 18, 2011 |